ClinConnect ClinConnect Logo
Search / Trial NCT06713343

Insertion of Laryngeal Mask Airways and Postoperative Sore Throat

Launched by ANKARA CITY HOSPITAL BILKENT · Nov 27, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Laryngeal Mask Airway Postoperative Sore Throat Lma

ClinConnect Summary

This clinical trial is looking at how the temperature at which laryngeal mask airways (LMA) are stored might affect patients' experiences of sore throat after surgery. The LMA is a device used to help patients breathe during general anesthesia. In the study, patients scheduled for elective surgeries will be divided into two groups. One group will receive an LMA that was stored at a cooler temperature (10 °C to 12 °C), while the other group will receive one stored at a warmer temperature (22 °C to 25 °C). Researchers want to see if the temperature of the LMA affects how many patients experience sore throat, difficulty swallowing, voice changes, or coughing after their surgery.

To participate in this trial, patients need to be between 18 and 65 years old and scheduled for a surgery that will last between 1 to 2 hours under general anesthesia. They should be in good health with a low to moderate risk for surgery. The study is currently recruiting participants, and those who join will be asked about their comfort and any throat issues at various times after their surgery. This trial aims to improve patient care and comfort following surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Under elective conditions, between 18-65 years of age, those who will receive general anesthesia and ventilation will be provided with a laryngeal mask airways
  • ASA I-III risk group
  • Patients who agreed to be included in the study
  • Estimated duration of anesthesia lasting between 1 hour and 2 hours
  • Exclusion Criteria:
  • Patients younger than 18 and older than 65 years old
  • Patients who are incapable of reading, understanding and signing the consent form
  • Hemodynamically unstable patients
  • Patients with orofacial clefts or abnormalities of the oral cavity or pharynx, patients who have undergone oral or laryngeal surgery
  • Patients at high risk of aspiration of gastric contents (pregnant women, those with gastro-esophageal reflux, those with hiatal hernia)
  • Patients do not want to participate in the study
  • Patients with sore throat in the last 30 days before surgeryPatients
  • Patients with advanced dementia
  • Patients with ASA score above III
  • Patients with a Mallampati score of 4
  • Emergency surgical procedures

About Ankara City Hospital Bilkent

Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.

Locations

Ankara, , Turkey

Ankara, Ankara, çankaya, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported